Normal lung growth following antenatal dexamethasone treatment for respiratory distress syndrome
Authors:
- 1 January 1988
- journal article
- clinical trial
- Published by Wiley in Pediatric Pulmonology
- Vol. 5 (1) , 27-30
Abstract
Antenatal steroid therapy reduces the incidence of respiratory distress syndrome (RDS) in premature infants. However, animal studies showed a decrease in lung cell number and lower lung weights in fetal rabbits exposed to hydrocortisone. This prompted us to measure flows and lung volumes (by spirometry and helium‐dilution method) in children > 6 years who were part of a study by the Collaborative Group on Antenatal Steroid Therapy. The effect of antenatal steroids on subsequent pulmonary function had not previously been studied. Of the 158 children originally enrolled before birth, a total of 8 dexamethasone (DEX)‐ and 11 placebo‐treated children were still local residents and fulfilled the criteria of the study (gestational age, 28–34 weeks; DEX/placebo treatment 1–7 days before delivery). Mean heights and weights were normal with no significant differences between the groups. Pulmonary function tests showed no differences in lung volumes or expiratory flows between the children whose mothers had received antenatal DEX and those who had received placebo. These results indicate no adverse effect of antenatal DEX on subsequent lung volumes and expiratory flows in childhood.Keywords
This publication has 15 references indexed in Scilit:
- Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infantsThe Journal of Pediatrics, 1986
- Effects of antenatal dexamethasone administration in the infant: Long-term follow-upThe Journal of Pediatrics, 1984
- School Progress and Cognitive Development of 6-Year-Old Children Whose Mothers Were Treated Antenatally with BetamethasonePediatrics, 1982
- Standardization of lung function testing in childrenThe Journal of Pediatrics, 1980
- Glucocorticoid prophylaxis for respiratory distress syndrome: A review of potential toxicityThe Journal of Pediatrics, 1975
- Reversible Inhibition of Lung Cell Number After Glucocorticoid Injection Into Fetal Rabbits to Enhance Surfactant AppearancePediatrics, 1974
- A CONTROLLED TRIAL OF ANTEPARTUM GLUCOCORTICOID TREATMENT FOR PREVENTION OF THE RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTSPediatrics, 1972
- Glucocorticoid Receptors and the Role of Glucocorticoids in Fetal Lung DevelopmentProceedings of the National Academy of Sciences, 1972
- Cortisol receptors in rabbit fetal lungBiochemical and Biophysical Research Communications, 1972
- Cortisone-Induced Growth Failure in Neonatal RatsPediatric Research, 1968